Main characteristics were similarly distributed among the inclusion criteria of MADIT II ( 24 % ) , SCD-HeFT ( 24 % ) , COMPANION ( 26 % ) and MADIT-CRT ( 18 % ) trials , while a small number of patients met the MUSTT and MADIT ( 7 % ) inclusion criteria .
